NANOVATIONTX Trademark

Trademark Overview


On Sunday, July 17, 2022, a trademark application was filed for NANOVATIONTX with the United States Patent and Trademark Office. The USPTO has given the NANOVATIONTX trademark a serial number of 97506782. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 2, 2024. This trademark is owned by NanoVation Therapeutics Inc.. The NANOVATIONTX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of can...

Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
nanovationtx

General Information


Serial Number97506782
Word MarkNANOVATIONTX
Filing DateSunday, July 17, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging
Pseudo MarkNANOVATION TX
Goods and ServicesPharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanoVation Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBritish Columbia V6T1Z3
CA

Trademark Events


Event DateEvent Description
Wednesday, July 20, 2022NEW APPLICATION ENTERED
Monday, August 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Thursday, June 1, 2023NON-FINAL ACTION WRITTEN
Thursday, June 1, 2023NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023NON-FINAL ACTION WRITTEN
Thursday, June 1, 2023NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2023SUSPENSION LETTER WRITTEN
Monday, October 2, 2023LETTER OF SUSPENSION E-MAILED
Monday, October 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 5, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, June 10, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 2, 2024ASSIGNED TO LIE
Wednesday, April 10, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 10, 2024SUSPENSION INQUIRY WRITTEN
Wednesday, April 10, 2024INQUIRY TO SUSPENSION E-MAILED